| Date | Title | Description |
| 15.09.2026 | AlphaPai Raises US$50 Million in Series B Funding as Financial AI Moves into the Depths of Professional Work | HONG KONG, Sept. 15, 2026 /PRNewswire/ -- AlphaPai, an AI investment research assistant developed by the financial AI company Rabyte Technology for professional investors, today announced the completion of a Series B funding round of US$50 ... |
| 08.09.2026 | Genlight Medical raises several hundred million yuan in C and D rounds | Genlight Medical has completed consecutive C and D financing rounds, raising several hundred million yuan in total. The C round was led by Qiming Venture Partners, while the D round was backed by Saizhi Bole, Kuanqiao Hengsong, Ningbo state... |
| 01.09.2026 | AusperBio Inks $120 Million Series C Financing |
SAN FRANCISCO, CA, AusperBio Therapeutics, a near-commercial biopharmaceutical company, announced the closing of its $120 million Series C financing.
>> Click here for more funding data on AusperBio
>> To export AusperBio fundi... |
| 30.08.2026 | AusperBio Secures $120M, Propels AHB-137 to Phase 3 for Hepatitis B Functional Cure | AusperBio secured $120 million Series C, raising total capital to $360 million. This substantial funding accelerates its lead candidate, AHB-137, into a pivotal Phase 3 program for chronic hepatitis B. The company aggressively pursues a fun... |
| 28.08.2026 | AusperBio Raises $120M in Series C Funding | AusperBio, a San Francisco, CA-based biopharmaceutical company focused on developing targeted oligonucleotide therapeutics for the treatment of chronic hepatitis B (CHB) and other diseases, raised $120M in Series C financing.
The round was ... |
| 28.08.2026 | AusperBio Raises $120 Million Series C As Total Funding Reaches $360 Million And AHB-137 Advances Through Phase 3 | AusperBio has closed a $120 million Series C financing to advance its chronic hepatitis B pipeline, including the Phase 3 registrational program and potential commercialization of its lead investigational therapy AHB-137. The financing brin... |
| 28.08.2026 | AusperBio Raises $120 Million To Push a Hepatitis B Functional Cure | Chronic hepatitis B affects over 250 million people in the world. What’s available as the solution today can only manage the virus, it can rarely cure it. So, most patients end up depending on drugs for life.
To solve this, Ausperbio raises... |
| 14.07.2026 | Marvel-Tech raises more than RMB500 million across two financing rounds | Shanghai-based Marvel-Tech, a developer of gas turbines and industrial waste-heat and waste-pressure recovery turbine systems, has completed two consecutive financing rounds totaling more than RMB500 million. The C round was led by HongShan... |
| 25.06.2026 | Venture capital floods China's "future industries"; fear of bubble surfaces | People walk on a pedestrian bridge at Lujiazui financial district in Shanghai, China, July 14, 2025. REUTERS/Go Nakamura/File Photo
Just two days after SpaceX made its historic market debut, a Chinese space startup held an investor roadshow... |
| 05.06.2026 | China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange | SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, listed on the Hong Kong Stock Exchange on June 5, 2... |
| 29.05.2026 | Qiming Venture Partners Managing Partner Alex Zhou Named to 2026 Forbes Midas List | SHANGHAI, May 29, 2026 /PRNewswire/ -- Forbes has released its 2026 Midas List, the definitive ranking of the world's top venture capital investors. Alex Zhou, Managing Partner at Qiming Venture Partners, debuts at No. 80, recognizing his t... |
| 27.05.2026 | Domestic Display Chip Leader Viewtrix Technology Listed on Hong Kong Stock Exchange | SHANGHAI, May 27, 2026 /PRNewswire/ -- Viewtrix Technology, a portfolio company of Qiming Venture Partners and a leading display chip design enterprise in China, successfully listed on the Hong Kong Stock Exchange, marking the sixth IPO for... |
| 06.05.2026 | Windward Bio Announces $165 Million Crossover Financing To Advance Long-Acting Immunology Pipeline | Windward Bio, a private, clinical-stage biotechnology company based in Basel, Switzerland, has announced an upsized $165 million crossover financing led by OrbiMed, with participation from RA Capital Management, Janus Henderson Investors, S... |
| 05.05.2026 | Windward Bio secures USD 165 million to advance clinical trials |
WIN378, Windward's lead program, is a next-generation, fully human monoclonal antibody that potently binds to the thymic stromal lymphopoietin (TSLP) ligand. This well-validated cytokine plays a key role in the development and progression ... |
| 25.04.2026 | Pulnovo Medical: $100 Million Financing Round Led By Medtronic Closed | Pulnovo Medical, a New York-based pioneer in breakthrough therapies for pulmonary hypertension and heart failure, has completed an oversubscribed $100 million strategic financing round led by Medtronic, one of the world’s largest medical te... |
| 22.04.2026 | Nasn moves closer to Hong Kong listing after CSRC filing | On April 17, the China Securities Regulatory Commission disclosed a filing notice regarding Nasn Automotive Electronics’ overseas offering and listing, as well as the full circulation of its domestic unlisted shares.
This indicates that Nas... |
| 20.04.2026 | Pulnovo Medical Raises $100M in Funding | Pulnovo Medical, a NYC-based developer of therapies for treating pulmonary hypertension and heart failure, raised $100M in funding.
The round was led by Medtronic, with participation from existing investors such as EQT, Qiming Venture Partn... |
| 04.04.2026 | Syneron Bio Fuels Innovation with $150M Investment | Syneron Bio secured $150 million in Series B financing. This major investment drives its intelligent Synova platform. The capital fuels advanced macrocyclic peptide drug discovery. It targets critical unmet needs across oncology, autoimmune... |
| 03.04.2026 | China's BMI Frontier: StairMed Fuels Next-Gen Human-Machine Integration | StairMed secured RMB 500 million ($69M) from Alibaba, Tencent, and others. This investment accelerates brain-machine interface (BMI) and neuromodulation development. The company progresses 256-channel BMI clinical trials in China, pioneerin... |
| 03.04.2026 | Syneron Bio Announces Completion of $150 Million Series B Financing | BEIJING, April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th. The round was led by an international ... |
| 03.04.2026 | Syneron Bio: $150 Million Raised For Macrocyclic Peptide Drug Discovery Platform And Pipeline Advancement | Syneron Bio announced the completion of a $150 million Series B financing round, strengthening its position as a developer of intelligent platform-driven macrocyclic peptide therapeutics and accelerating its push toward clinical development... |
| 03.04.2026 | Syneron Bio Closes $150M Series B Financing | Syneron Bio, a Beijing, China-based intelligent platform-driven macrocyclic peptide drug discovery company, closed a $150m Series B financing round.
The round was led by an international life-science fund, with co-lead participation from De... |
| 02.04.2026 | StairMed Secures RMB 500 Million Financing Led by Alibaba, Joined by Tencent | SHANGHAI, April 2, 2026 /PRNewswire/ -- Shanghai StairMed Technology Co., Ltd. ("StairMed" or "the Company") recently announced the closing of a strategic financing round totaling RMB 500 million. The round was led by Al... |
| 02.04.2026 | CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala | SHANGHAI, April 2, 2026 /PRNewswire/ -- The 12th Annual China Healthcare Investment Conference (CHIC 2026) capped the first day of its two-day program with a celebratory Awards Gala Dinner held at The Ritz-Carlton Hotel Pudong, Shanghai. Th... |
| 23.03.2026 | The OpenClaw wave is bigger in China than elsewhere in the world: Qiming Venture Partners | Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET |
| 17.03.2026 | RoboForce Secures $52M to Propel Industrial AI Robotics | RoboForce secures $52 million in new funding. This propels the company's Physical AI robotics for industrial labor. The capital accelerates robot foundation model development, manufacturing scale, and commercial deployments. Total funding n... |
| 16.03.2026 | RoboForce: $52 Million Raised To Scale Physical AI Robo-Labor | RoboForce, a developer of Physical AI-powered robotics systems for industrial labor, announced it has raised $52 million in an oversubscribed funding round as it moves from research and development toward scaled commercial deployments. The ... |
| 16.03.2026 | RoboForce raises $52M to develop physical AI robots for industrial labor
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Robotics startup RoboForce Inc. announced today that it has raised $52 million in new funding to accelerate its next-generation robot foundation model, scale up general-purpose physical artificial intelligence robots and drive manufacturing... |
| 13.03.2026 | Alibaba leads RMB 500 million investment in BCI startup StairMed | StairMed, a brain-computer interface (BCI) developer, has secured RMB 500 million (USD 72.7 million) in a funding round led by Alibaba Group, with participation from SDIC Unity Capital. Existing investors including Tencent, FountainBridge C... |
| 02.03.2026 | XellSmart Receives Fourth Consecutive US FDA & China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy | SUZHOU, China, March 2, 2026 /PRNewswire/ -- In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with i... |
| 11.02.2026 | Chinese Edge AI Chip Leader Axera Lists on Hong Kong Stock Exchange | SHANGHAI, Feb. 11, 2026 /PRNewswire/ -- Axera, a portfolio company of Qiming Venture Partners and a leading Chinese edge AI chip company, successfully listed on the Hong Kong Stock Exchange on February 10th, 2026, Beijing time, becoming the... |
| 10.02.2026 | SenseTime-backed robotics startup ACE Robotics closes angel round led by Ant Group | China-based artificial intelligence company SenseTime said today that embodied robotics startup ACE Robotics has completed an angel round, raising an undisclosed amount, led by Ant Group. Qiming Venture Partners, GVC, Hony Capital, Lenovo C... |
| 10.02.2026 | ShengShu Technology Completes Series A+ Funding of Over RMB 600 Million | has completed a Series A+ funding round of over RMB 600 million. The round was co-led by Zhongguancun Science City and LINK-X CAPITAL, with strategic investments from Wondershare, Visual China Group Co., Ltd., and TRS. Existing investors, i... |
| 05.02.2026 | Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market | SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Insight Lifetech, a portfolio company of Qiming Venture Partners and a leading Chinese innovative medical device manfaucturer, successfully listed on the Shanghai Stock Exchange's STAR Market on Februa... |
| 05.02.2026 | ShengShu Technology: Multimodal Video Model Developer Raises RMB 600M+ Series A+ | ShengShu Technology said it has completed a Series A+ funding round of more than RMB 600 million as it scales development and commercialization of its multimodal foundation models, including its Vidu video generation platform. The round was... |
| 05.02.2026 | ShengShu Technology Raises Over RMB 600M in Series A+ Funding | ShengShu Technology, a Beijing, China-based company providing multimodal generative AI models for various applications, raised over RMB 600M in Series A+ funding.
The round was co-led by Zhongguancun Science City and LINK-X CAPITAL, with pa... |
| 05.02.2026 | ShengShu Technology Completes Series A+ Funding of Over RMB 600 Million | Leveraging Multimodal Foundation Models to Unlock AI Productivity in Digital and Physical Worlds
SINGAPORE, Feb. 5, 2026 /PRNewswire/ -- ShengShu Technology has completed a Series A+ funding round of over RMB 600 million. The round was co-l... |
| 02.02.2026 | Tenpoint Therapeutics Secures $235M, Prepares YUVEZZI Launch for Presbyopia | Tenpoint Therapeutics secured $235 million in new capital. This robust funding fuels the impending launch of YUVEZZI. YUVEZZI is an FDA-approved, first-of-its-kind dual-agent eye drop. It targets presbyopia, a widespread aging vision condit... |
| 01.02.2026 | China's AI Future: Hardware Dilemma Meets Funding Boom | China's AI sector navigates a complex duality. Top tech giants like Alibaba, Tencent, and ByteDance receive conditional approval to acquire 400,000 advanced Nvidia H200 AI accelerators. This move signals Beijing's pragmatic concession amid ... |
| 30.01.2026 | Baidu-backed new energy truck developer DeepWay raises $170m ahead of IPO | DeepWay Technology, the Baidu-backed Chinese new energy heavy-duty trucks developer which is in the process of a Hong Kong listing, has secured 1.177 billion yuan (almost $170 million) in a pre-IPO financing led by Puhua Capital.
DeepWay, w... |
| 30.01.2026 | Tenpoint Therapeutics: $235 Million Raised To Launch YUVEZZI Presbyopia Eye Drop | Tenpoint Therapeutics has secured $235 million in new funding to support the planned commercialization of its presbyopia treatment, YUVEZZI. The company said the capital combines an $85 million Series B preferred stock financing and a $150 ... |
| 29.01.2026 | As AI consolidates, what makes StepFun worth a RMB 5 billion raise? | StepFun’s Series B+ funding round, exceeding RMB 5 billion (USD 700 million), has drawn attention for its size. The investor mix and the speed at which the round closed are equally revealing. From launch to completion, the process took roug... |
| 29.01.2026 | Tenpoint Therapeutics: $235 Million Raised To Launch Dual Agent Presbyopia Eye Drop YUVEZZI | Tenpoint Therapeutics said it has secured $235 million in new capital, combining an $85 million Series B preferred stock financing with a $150 million senior secured term loan facility, as the company prepares to commercialize its newly app... |
| 26.01.2026 | Chinese AI Firm Stepfun Raises USD719 Mln for Model Development, AI Agent Rollout | (Yicai) Jan. 26 -- Stepfun, a Chinese artificial intelligence startup working closely with car giant Geely Automobile Holdings, has secured about CNY5 billion (USD719 million) to fast-track foundational model development, deploy AI agents, ... |
| 26.01.2026 | Shanghai AI unicorn StepFun raises over $718 million in B+ round | Shanghai-based large-model startup StepFun has completed a B+ financing round exceeding RMB 5 billion ($718 million), setting a new record for the largest single financing in China’s large-model sector over the past 12 months. The round saw... |
| 26.01.2026 | China’s investors double down on AI frontrunners as StepFun raises RMB 5 billion | StepFun has raised more than RMB 5 billion (USD 700 million) in a Series B+ funding round, according to PEdaily. The deal ranks among the largest private financings in China’s artificial intelligence sector so far this year.
The round drew ... |
| 12.01.2026 | Qiming-backed biotech Oricell raises $70m Series C1 round | - |
| 08.01.2026 | China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange | SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Qiming Venture Partners' portfolio company Z.ai (formerly known as Zhipu AI), a pioneer and leader inartificial general intelligence (AGI) in China, successfully listed on the Hong Kong Stock Exchange ... |
| 05.01.2026 | GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy | HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) h... |
| 02.01.2026 | Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange | SHANGHAI, Jan. 2, 2026 /PRNewswire/ -- Qiming Venture Partners' portfolio company Biren Technology, a leading domestic GPU developer, successfully listed on the Hong Kong Stock Exchange today, becoming the first company to go public in Hong... |
| 17.12.2025 | RedotPay raises $107M Series B led by Goodwater for stablecoin payments | - |
| 08.12.2025 | Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond | SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today announced the closing of a $10 million Seed finan... |
| 30.11.2025 | Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery | SHANGHAI, Nov. 30, 2025 /PRNewswire/ -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings in Wang Fuk Court in Tai Po, Hong Kong, causing severe casualties and drawing widespread public conce... |
| 24.11.2025 | GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics | Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology
Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs
SEOUL,... |
| 24.11.2025 | ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics | Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology
Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs
SEOUL,... |
| 17.11.2025 | Early Xiaomi backer Qiming targets $600m for ninth flagship USD fund: SEC filing | - |
| 14.11.2025 | Qiming goes smaller with new fund amid waning LP interest in China | - |
| 16.10.2025 | Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange | SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Yunji Technology, a global leader in the hospitality robotic-based AI agents market and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock Exchange on Octo... |
| 26.09.2025 | AusperBio Secures $63 Million for Targeted Hepatitis B Cure | AusperBio, a clinical-stage biotechnology firm, closed a $63 million Series B2 funding round. This substantial capital infusion will accelerate its mission. The company develops targeted oligonucleotide therapies. Its lead candidate, AHB-13... |
| 23.09.2025 | AusperBio: $63 Million Closed For Advancing Targeted Oligonucleotide Therapies | AusperBio, a biotechnology company focused on curing chronic hepatitis B, has announced it raised $63 million in Series B2 funding. This new investment adds to the strong financial backing the company has already received and reflects growi... |
| 22.09.2025 | AusperBio Raises $63M in Series B2 Funding | AusperBio, a San Francisco, CA-based privately held clinical-stage biotechnology company, raised $63M in Series B2 Funding.
The round was led by Qiming Venture Partners with participation from HanKang Capital, CDH Investments, YuanBio Ventu... |
| 08.09.2025 | Epigenic Therapeutics Closes $60M Series B Financing | Epigenic Therapeutics, a Shanghai, China-based clinical-stage drug development company, raised $60M in Series B funding.
The round was led by Lapam Capital, with participation from existing investors Qiming Venture Partners and OrbiMed, and... |
| 08.09.2025 | Epigenic Therapeutics Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic Medicines | SHANGHAI, Sept. 8, 2025 /PRNewswire/ -- Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series B round of financing led by Lapam Capital, wi... |
| 19.08.2025 | Early Xiaomi Backer Qiming Slashes Fund Goal to $600 Million | - |
| 11.08.2025 | Minghui Pharmaceutical Raises USD 131M in Pre-IPO Financing | Minghui Pharmaceutical, a Singapore-based clinical biopharmaceutical company, raised USD 131M Pre-IPO financing.
The round was led by new investors OrbiMed and co-led by Qiming Venture Partners with participation from existing investor TF C... |
| 10.08.2025 | OrbiMed, Qiming lead $131m pre-IPO financing for late-stage clinical biopharma Minghui | Global healthcare investment firm OrbiMed and Qiming Venture Partners have jointly led a pre-IPO financing of $131 million in Minghui Pharmaceutical, a Chinese late-stage clinical biopharmaceutical company, according to a statement.
Shangha... |
| 07.08.2025 | Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing to Advance Late-Stage Pipeline and Global Expansion | SHANGHAI, Aug. 7, 2025 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 million Pre-IPO financing led by new investors OrbiMed and co-led... |
| 28.07.2025 | XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury | SUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational clinical trial. This Phas... |
| 28.07.2025 | China’s latest AI model claims to be even cheaper to use than DeepSeek | Startup Z.ai, formerly known as Zhipu, announced Monday that its new GLM-4.5 AI model would cost less than DeepSeek to use.
Like DeepSeek, the new model is also open source and can be downloaded for free.
At about half the size of DeepSeek’... |
| 28.07.2025 | Chinese startup Z.ai launches powerful open source GLM-4.5 model family with PowerPoint creation | Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now
Another week in the summer of 2025 has begun, and in a continuation of the trend fr... |
| 10.07.2025 | Renasant Bio Raises $54.5M in Seed Funding | Renasant Bio, a Berkeley, CA-based developer of disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD), raised $54.5M in Seed funding.
The round was led by 5AM Ventures, alongside other life sciences investors... |
| 30.06.2025 | Qiming Venture Partners' Portfolio Company Unisound Successfully Lists on the Hong Kong Stock Exchange | SHANGHAI, June 30, 2025 /PRNewswire/ -- On June 30th, Beijing time, Unisound, a pioneer in the industrialization of AI technologies in China and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock... |
| 08.06.2025 | GenEditBio and Newborn Town: Pioneering Innovations in Hong Kong's Biotechnology and Entertainment Sectors | In the bustling heart of Hong Kong, two companies are making waves in their respective fields. GenEditBio, a biotechnology start-up, is pushing the boundaries of genetic medicine. Meanwhile, Newborn Town, a social entertainment giant, is re... |
| 06.06.2025 | GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World's First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal D... | HONG KONG, BEIJING and BOSTON, June 6, 2025 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology start-up company focusing on genome editing therapeutic solutions through the discovery of novel and pre... |
| 05.06.2025 | LP behind 'China's Silicon Valley' to back funds of Qiming, Monolith, others | Zhongguancun Science City (ZGC Science City), a local government investment firm in Beijing, will invest in funds managed by Qiming Venture Partners, Monolith Management, and Meituan’s DragonBall Capital, among two others, amid the growing ... |
| 09.05.2025 | The AIoT Revolution: Terminus Group and the Future of Smart Connectivity | The world is on the brink of a technological renaissance. By 2025, over 30 billion devices will be connected globally. This surge is not just a number; it’s a revolution. At the heart of this transformation lies AIoT—Artificial Intelligence... |
| 07.05.2025 | Budget brand no more? Pelliot readies Hong Kong IPO after profit surge | Pelliot first signaled its IPO ambitions in August 2023, when it filed for listing guidance with the Anhui arm of the China Securities Regulatory Commission. The goal was a debut on the Shenzhen Stock Exchange. But by April 2025, the compan... |
| 05.05.2025 | China’s PE-VC market braces for shakeup as tough times weed out trailing GPs | The ongoing reshuffle in Greater China’s private investment market is expected to intensify as significant macro challenges eliminate trailing managers with unwanted “zombie funds”. |
| 04.04.2025 | Streaming Giants and Storytelling Startups: A Tale of Triumph and Transition in India’s Digital Landscape | In the vast digital landscape of India, two narratives unfold: the roaring success of Amazon MX Player’s “Aashram” and the turbulent journey of Pratilipi, a digital storytelling platform. Both stories reflect the changing tides of entertain... |
| 04.04.2025 | Digital storytelling platform Pratilipi Raises USD 20 Mn in Series E round led by Jungle Ventures The Gurugram-based firm plans to utilise the funds to diversify into new storytelling formats such as ... | Digital storytelling platform Pratilipi has raised USD 20 million in its Series E round, led by Jungle Ventures.
The round includes USD 12 million in primary capital from two individual investors and USD 8 million via secondary share sales.... |
| 03.04.2025 | Jungle Ventures leads Series E funding in Pratilipi as Chinese VCs exit, valuation drops | Ranjeet Pratap Singh, co-founder and CEO, Pratilipi
Singapore-based venture capital firm Jungle Ventures has led a Series E funding round of $20 million (about Rs 171 crore) in digital storytelling platform Pratilipi.
The round includes $12... |
| 01.04.2025 | Aramco's Prosperity7 leads $73m financing in China's Spirit AI | Prosperity7 Ventures, a venture capital (VC) fund of Saudi oil giant Aramco, has led a Series Pre-A funding round of 528 million yuan ($72.8 million) in China’s Spirit AI amid a frenzy of early-stage financing in embodied intelligence.
Spir... |
| 12.03.2025 | DeepSeek AI cranks open the spigots on Chinese venture capital | DeepSeek’s artificial intelligence breakthrough has led to an “avalanche” of interest in Chinese tech firms over recent months.
It could mark a much-needed boost for the country’s investment landscape. VC investment into China-based compani... |
| 03.03.2025 | Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing | SHANGHAI, March 3, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This roun... |
| 25.02.2025 | Chip firm Biren plans Hong Kong IPO to raise $300 million funding, sources say | Chinese chip company Biren Technology is planning a Hong Kong IPO to raise around $300 million and is working with China International Capital Corporation, Bank of China International, and Ping An Securities on the potential stock sale, whi... |
| 19.02.2025 | China Digest: Nisa Leung departs from Qiming; Hony Capital to manage new Qianhai fund | Nisa Leung has officially stepped down from her position as a managing partner of Qiming Venture Partners, while China’s Hony Capital is the manager of a new fund. |
| 14.02.2025 | Deals in brief: Finmo’s Series A round hits oversubscription, Giftaway and HD raise fresh capital, latest China deals, and more | Finmo raises Series A funding to expand treasury management platform
Finmo, a treasury operating system provider, has raised USD 18.5 million in an oversubscribed Series A funding round, bringing its total funding to USD 27 million. The rou... |
| 13.02.2025 | New Blood in Innovation: Frank Yin Joins Washington Research Foundation | In the bustling world of innovation, fresh talent can spark a revolution. Frank Yin, Ph.D., is the latest addition to the Washington Research Foundation (WRF) as an investment associate. His mission? To unearth and nurture startup opportuni... |
| 13.02.2025 | Frank Yin joins Washington Research Foundation staff as investment associate | Washington Research Foundation
Yin's role will primarily focus on identifying and evaluating startup investment opportunities to advance Washington state innovations for public benefit
SEATTLE, Feb. 13, 2025 /PRNewswire-PRWeb/ -- Frank Yin,... |
| 20.01.2025 | Umoja Biopharma's $100 Million Leap: A New Era for In Vivo CAR T Cell Therapies | Umoja Biopharma is on the rise. The Seattle-based company has just secured $100 million in Series C financing. This is not just a number; it’s a statement. It signals a bold step forward in the world of biotechnology. The funding round was ... |
| 20.01.2025 | Umoja Biopharma Raises $100M in Series C Financing | Umoja Biopharma, a Seattle, WA-based clinical-stage company which specializes in vivo cell therapies, raised $100M Series C financing.
The round was led by Double Point Ventures and DCVC Bio, with participation from new and existing investo... |
| 14.01.2025 | Windward Bio: Charting New Waters in Immunology with $200 Million Series A Financing | In the vast ocean of biopharmaceutical innovation, Windward Bio has set sail with a robust $200 million Series A financing. This private, clinical-stage company aims to navigate the turbulent waters of immunological diseases, focusing on se... |
| 13.01.2025 | Windward Bio launches with $200 million Series A financing round |
Windward Bio’s lead candidate, WIN378, which has been in-licensed from Kelun-Biotech and Harbour BioMed, is a potential best-in-class, long-acting monoclonal antibody targeting the ligand of thymic stromal lymphopoietin (TSLP) that has the... |
| 13.01.2025 | PE major EQT anchors Cornerstone Robotics's $70m funding | Swedish investment house EQT Group has anchored the $70-million Series C funding round in Hong Kong-headquartered surgical robotics firm Cornerstone Robotics, according to an announcement.
The round also saw the participation of a number of... |
| 26.12.2024 | Chinese AI model maker Stepfun raises hundreds of millions in Series B funding
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to pr... | Chinese generative artificial intelligence model maker Stepfun has reportedly closed on a bumper funding round worth “several hundred million dollars” from a host of investors including state-owned private equity firms and local technology ... |
| 08.12.2024 | Soda Health: Health Tech Company Raises $50 Million (Series B) | Soda Health – a health tech company enhancing the use of benefit dollars to improve health outcomes and reduce inequities – announced a $50 million Series B financing. General Catalyst led the round with additional capital from former Human... |
| 04.12.2024 | Soda Health Raises $50M in Series B Funding | Soda Health, a Bentonville, AR-based health tech company enhancing the use of benefit dollars to improve health outcomes and reduce inequities, raised $50M in Series B funding.
The round was led by General Catalyst, with additional capital ... |
| 26.11.2024 | Shifting Sands: The Evolution of Investment Strategies in a Global Landscape | In the world of finance, change is the only constant. Recently, two stories emerged that highlight this truth. One is the leadership transition at Qiming Venture Partners, a major player in Chinese venture capital. The other is the growing ... |
| 25.11.2024 | Chinese VC firm Qiming Venture Partners prepares for leadership change | After months of speculation, leadership changes at Qiming Venture Partners have been confirmed.
Nisa Leung, a managing partner with 18 years at the firm, is stepping down, according to ChinaVenture. This move aligns with Qiming’s “ten-year ... |
| 16.11.2024 | Китайский стартап представил инструмент, генерирующий видео по картинкам лучше, чем Sora от OpenAI | Пекинская компания Shengshu Technology заявила, что ее инструмент Vidu для преобразования текста в видео на основе искусственного интеллекта теперь может генерировать видеоролики, объединяя несколько изображений, тем самым составляя конкуре... |
